These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7135889)

  • 21. Immunoglobulin dosage and switch from intravenous to subcutaneous immunoglobulin replacement therapy in patients with primary hypogammaglobulinemia: decreasing dosage does not alter serum IgG levels.
    Thépot S; Malphettes M; Gardeur A; Galicier L; Asli B; Karlin L; Gérard L; Laumont R; Doize ML; Arnulf B; Fieschi C; Bengoufa D; Oksenhendler E
    J Clin Immunol; 2010 Jul; 30(4):602-6. PubMed ID: 20393788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in the half-life and clearance of IgG during therapy with intravenous gamma-globulin in 16 patients with severe primary humoral immunodeficiency.
    Schiff RI; Rudd C
    J Clin Immunol; 1986 May; 6(3):256-64. PubMed ID: 2424931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Variable immune deficiency syndrome with antibody deficiency--long-term substitution with immunoglobulins].
    Vaith P; Maas D
    Immun Infekt; 1984 Apr; 12(2):123-8. PubMed ID: 6442916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evaluation of the safety of three intravenous immunoglobulin preparations in patients with primary hypogammaglobulinaemia.
    Yap PL; McClelland DB
    J Infect; 1986 Jan; 12(1):5-10. PubMed ID: 3082994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of intravenous immunoglobulins: recommendations of a consensus conference of the working group of immunology of the Italian Society of Pediatrics.
    Ann Allergy; 1989 Apr; 62(4):362-7. PubMed ID: 2495747
    [No Abstract]   [Full Text] [Related]  

  • 26. Intramuscular and intravenous administration of immunoglobulin to patients with hypogammaglobulinemia.
    Hanson LA; Björkander J; Wadsworth C
    Birth Defects Orig Artic Ser; 1983; 19(3):205-7. PubMed ID: 6652239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease.
    Cunningham-Rundles C; Siegal FP; Smithwick EM; Lion-Boulé A; Cunningham-Rundles S; O'Malley J; Barandun S; Good RA
    Ann Intern Med; 1984 Oct; 101(4):435-9. PubMed ID: 6206756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1040 prophylactic infusions with an unmodified intravenous immunoglobulin product causing few side-effects in patients with antibody deficiency syndromes.
    Björkander J; Wadsworth C; Hanson LA
    Infection; 1985; 13(3):102-10. PubMed ID: 4030106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increase of serum immunoglobulin level into the normal range in primary hypogammaglobulinaemia by dosage individualization of intravenous immunoglobulin.
    Leen CL; Yap PL; McClelland DB
    Vox Sang; 1986; 51(4):278-86. PubMed ID: 3798863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High- vs low-dose immunoglobulin therapy in the long-term treatment of X-linked agammaglobulinemia.
    Liese JG; Wintergerst U; Tympner KD; Belohradsky BH
    Am J Dis Child; 1992 Mar; 146(3):335-9. PubMed ID: 1543181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered immunoglobulin status in congenital nephrotic syndrome.
    Harris HW; Umetsu D; Geha R; Harmon WE
    Clin Nephrol; 1986 Jun; 25(6):308-13. PubMed ID: 3731545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical uses of intravenous immune globulin: immunoglobulin replacement therapy and treatment of autoimmune cytopenias.
    Sorensen RU; Kallick MD
    J Clin Apher; 1988; 4(2-3):97-103. PubMed ID: 3397376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of Hizentra(®) in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy.
    Jolles S; Bernatowska E; de Gracia J; Borte M; Cristea V; Peter HH; Belohradsky BH; Wahn V; Neufang-Hüber J; Zenker O; Grimbacher B
    Clin Immunol; 2011 Oct; 141(1):90-102. PubMed ID: 21705277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Individualizing the dose of intravenous immune serum globulin for therapy of patients with primary humoral immunodeficiency.
    Schiff RI
    Vox Sang; 1985; 49 Suppl 1():15-24. PubMed ID: 2416124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of monomeric immunoglobulin G (IgG) on the clearance of soluble aggregates of IgG in man.
    Halma C; Daha MR; van der Meer JW; Cohen A; van Furth R; Breedveld FC; Evers-Schouten JH; Pauwels EK; van Es LA
    J Clin Lab Immunol; 1991 May; 35(1):9-15. PubMed ID: 1668290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of hypogammaglobulinemia of prematurity with intravenous immune globulin.
    Ruderman JW; Peter JB; Gall RC; Stewart ME; Pomerance JJ; Stiehm ER
    J Perinatol; 1990 Jun; 10(2):150-5. PubMed ID: 2358899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous immune serum globulin replacement in hypogammaglobulinemia. A comparison of high- versus low-dose therapy.
    Gelfand EW; Reid B; Roifman CM
    Monogr Allergy; 1988; 23():177-86. PubMed ID: 3386639
    [No Abstract]   [Full Text] [Related]  

  • 38. Carimune NF Liquid is a safe and effective immunoglobulin replacement therapy in patients with primary immunodeficiency diseases.
    Berger M; Cunningham-Rundles C; Bonilla FA; Melamed I; Bichler J; Zenker O; Ballow M
    J Clin Immunol; 2007 Sep; 27(5):503-9. PubMed ID: 17479360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-infusion of intravenous immunoglobulin by immunodeficient patients at home.
    Ochs HD; Lee ML; Fischer SH; Delson ES; Chang BS; Wedgwood RJ
    J Infect Dis; 1987 Oct; 156(4):652-4. PubMed ID: 3624908
    [No Abstract]   [Full Text] [Related]  

  • 40. Prophylactic intravenous administration of immune globulin in preterm infants: effect on serum immunoglobulin concentrations during the first year of life.
    Kanakoudi-Tsakalidou F; Drossou-Agakidou V; Pratsidou P; Pardalos G; Andreou A
    J Pediatr; 1991 Oct; 119(4):624-9. PubMed ID: 1919896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.